Paired Expression Analysis of Tumor Cell Surface Antigens

Paired Expression Analysis of Tumor Cell Surface Antigens

Adoptive immunotherapy with antibody-based therapy or with T cells transduced to express chimeric antigen receptors (CARs) is useful to the extent that the cell surface membrane protein being targeted is not expressed on normal tissues. The most successful CAR-based (anti-CD19) or antibody-based the...

Full description

Bibliographic Details
Main Authors:	Rimas J. Orentas, Sivasish Sindiri, Christine Duris, Xinyu Wen, Jianbin He, Jun S. Wei, Jason Jarzembowski, Javed Khan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-08-01
Series:	Frontiers in Oncology
Subjects:	neuroblastoma gene expression profiling chimeric antigen receptor-T cells immunotherapy GFRA3 GFRA2
Online Access:	http://journal.frontiersin.org/article/10.3389/fonc.2017.00173/full

Similar Items

GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance
by: Mihwa Kim, et al.
Published: (2018-04-01)

Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4
by: Vijay G. Bhoj, et al.
Published: (2021-03-01)

In Vitro and In Vivo Determinations of The Anti-GDNF Family Receptor Alpha 1 Antibody in Mice by Immunochemistry and RT-PCR
by: Hossein Azizi, et al.
Published: (2020-10-01)

LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p/GFRA1 axis
by: Zhang Jinshan, et al.
Published: (2020-12-01)

Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
by: Rimas J Orentas, et al.
Published: (2014-06-01)

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
by: Rongfang He, et al.
Published: (2017-10-01)

Identification of cell surface proteins as potential immunotherapy targets in twelve pediatric cancers
by: Rimas J Orentas, et al.
Published: (2012-12-01)

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
by: Mahmoud Hassani, et al.
Published: (2020-03-01)

MYCN: From Oncoprotein To Tumor-Associated Antigen
by: Vito ePistoia, et al.
Published: (2012-11-01)

Construction and Functional Characterization of a Fully Human Anti-mesothelin Chimeric Antigen Receptor (CAR) Expressing T Cell
by: Leila Jafarzadeh, et al.
Published: (2020-06-01)

Chimeric Antigen Receptor-Engineered T Cells in Tumor Immunotherapy: From Bench to Beside
by: Peng WANG
Published: (2017-06-01)

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
by: Mahmoud Hassani, et al.
Published: (2020-03-01)

Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2017-12-01)

Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer
by: Yan W, et al.
Published: (2019-09-01)

Foreign or Domestic CARs: Receptor Ligands as Antigen-Binding Domains
by: Donald R. Shaffer, et al.
Published: (2014-01-01)

Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2019-04-01)

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
by: Mingxue Fan, et al.
Published: (2017-08-01)

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
by: Dongfang Liu, et al.
Published: (2020-08-01)

Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
by: Tahereh Soltantoyeh, et al.
Published: (2021-06-01)

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
by: Paris Kosti, et al.
Published: (2018-05-01)

Chimeric antigen receptor T-cells for glioblastoma: The journey ahead
by: Sujith Kurian Joseph, et al.
Published: (2019-01-01)

Immunotherapy for B-Cell Neoplasms using T Cells expressing Chimeric Antigen Receptors : From antigen choice to clinical implementation
by: Mohamed-Rachid Boulasse, et al.
Published: (2012-08-01)

You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
by: Aline Pfefferle, et al.
Published: (2020-03-01)

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
by: Elizabeth L. Siegler, et al.
Published: (2020-08-01)

Chimeric antigen receptor T cell therapies for multiple myeloma
by: Chao Wu, et al.
Published: (2019-11-01)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
by: Mohamed-Reda Benmebarek, et al.
Published: (2019-03-01)

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
by: Olaf Oberschmidt, et al.
Published: (2017-06-01)

Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†
by: Zhang Xu, et al.
Published: (2019-07-01)

Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
by: Carmen Alvarez‐Fernández, et al.
Published: (2021-01-01)

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
by: Giuseppe Schepisi, et al.
Published: (2020-09-01)

The Chimeric Antigen Receptor Detection Toolkit
by: Yifei Hu, et al.
Published: (2020-08-01)

The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies
by: Andriy Zhylko, et al.
Published: (2020-07-01)

Tumor mRNA-Transfected Dendritic Cells Stimulate the Generation of CTL That Recognize Neuroblastoma-Associated Antigens, Kill Tumor Cells: Immunotherapeutic Implications
by: Fabio Morandi, et al.
Published: (2006-10-01)

Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
by: Ewelina Grywalska, et al.
Published: (2020-04-01)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
by: Rohtesh S. Mehta, et al.
Published: (2018-02-01)

PSCA is a target of chimeric antigen receptor T cells in gastric cancer
by: Di Wu, et al.
Published: (2020-01-01)

Expression and purification of recombinant HTLV-I/-II linear epitopes antigen and its application for screening of suspected patients
by: Roxana Faramarzi, et al.
Published: (2017-05-01)

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
by: Stefan Stoiber, et al.
Published: (2019-05-01)

Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
by: Artemis Gavriil, et al.
Published: (2020-08-01)

Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies
by: Faizan Ahmad
Published: (2020-01-01)